Degarelix vs. leuprorelin for the treatment of prostate cancer in China: A cost-utility analysis

ObjectiveTo explore the cost-effectiveness of degarelix acetate for injection (degarelix) compared to leuprorelin in prostate cancer (Pca) castration treatment from Chinese healthcare system perspective.MethodsA Markov model, adapted from the one established in Finland was conducted for the cost-eff...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Jianzhou Yan (Egilea), Caiyun Li (Egilea), Xuefang Zhang (Egilea), Luyan Cheng (Egilea), Ruilin Ding (Egilea), Lingli Zhang (Egilea)
Formatua: Liburua
Argitaratua: Frontiers Media S.A., 2022-07-01T00:00:00Z.
Gaiak:
Sarrera elektronikoa:Connect to this object online.
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Internet

Connect to this object online.

3rd Floor Main Library

Aleari buruzko argibideak 3rd Floor Main Library
Sailkapena: A1234.567
Alea 1 Eskuragarri